Tratamiento de los factores de riesgo vascular en el paciente mayor de 80 años

Gómez‐Huelgas, Ricardo; Martínez‐Sellés, Manuel; Formiga, Francesç; Sánchez, José Juan Alemán; Camafort, Miguel; Galve, Enrique; Gil, Pedro; Lobos, José María

doi:10.1016/j.medcli.2014.04.001

Cited by 19 publications

(3 citation statements)

References 102 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Se ha publicado, por primera vez en Españ a, un documento de consenso sobre el tratamiento de los factores de riesgo vascular de los octogenarios 56 . Se insiste en la modificació n de los estilos de vida, un objetivo de PA má s laxo ( 150/90 mmHg o 160/90 mmHg si hay intolerancia o comorbilidad relevante), evitando la PA sistó lica < 120 mmHg y la diastó lica < 80 mmHg.…”

Section: Pacientes Ancianosunclassified

Novedades en cardiología: riesgo vascular y rehabilitación cardiaca

Galve

Cordero

Bertomeu‐Martínez

et al. 2015

Revista Española de Cardiología

Self Cite

View full text Add to dashboard Cite

Section: Pacientes Ancianosunclassified

Novedades en cardiología: riesgo vascular y rehabilitación cardiaca

Galve

Cordero

Bertomeu‐Martínez

et al. 2015

Revista Española de Cardiología

Self Cite

View full text Add to dashboard Cite

“…56 The document stresses lifestyle modifications, a less stringent BP target ( 150/90 mmHg or 160/90 mmHg if there is intolerance or relevant comorbidity), and avoiding systolic BP < 120 mmHg and diastolic BP < 80 mmHg. The remaining recommendations are summarized in Figure 3.…”

Section: Elderly Patientsmentioning

confidence: 99%

Update in Cardiology: Vascular Risk and Cardiac Rehabilitation

Galve

Cordero

Bertomeu‐Martínez

et al. 2015

Revista Española de Cardiología (English Edition)

Self Cite

View full text Add to dashboard Cite

As in other fields, understanding of vascular risk and rehabilitation is constantly improving. The present review of recent epidemiological update shows how far we are from achieving good risk factor control: in diet and nutrition, where unhealthy and excessive societal consumption is clearly increasing the prevalence of obesity; in exercise, where it is difficult to find a balance between benefit and risk, despite systemization efforts; in smoking, where developments center on programs and policies, with the electronic cigarette seeming more like a problem than a solution; in lipids, where the transatlantic debate between guidelines is becoming a paradigm of the divergence of views in this extensively studied area; in hypertension, where a nonpharmacological alternative (renal denervation) has been undermined by the SYMPLICITY HTN-3 setback, forcing a deep reassessment; in diabetes mellitus, where the new dipeptidyl peptidase-4 and sodium-glucose cotransporter type 2 inhibitors and glucagon like peptide 1 analogues have contributed much new information and a glimpse of the future of diabetes treatment, and in cardiac rehabilitation, which continues to benefit from new information and communication technologies and where clinical benefit is not hindered by advanced diseases, such as heart failure. Our summary concludes with the update in elderly patients, whose treatment criteria are extrapolated from those of younger patients, with the present review clearly indicating that should not be the case.

show abstract

“…En 2014 se publicó el documento español de consenso sobre tratamiento de factores de riesgo vascular en paciente mayor de 80 años, en el que colaboró nuestra Sociedad de Medicina Familiar y Comunitaria (semFYC) 1 .…”

unclassified